Kangji Medical Posts Strong Mid-Year Financials

Kangji Medical Holdings Limited (HK:9997) has released an update.

Kangji Medical Holdings Limited reported a robust interim financial performance for the first half of 2024, with a revenue increase of 13.6% and a net profit jump of 11.9% compared to the same period in 2023. The growth has been attributed primarily to a surge in sales of disposable products. Despite these strong results, the company has decided not to issue an interim dividend for the period.

For further insights into HK:9997 stock, check out TipRanks’ Stock Analysis page.